no image available Dickens & Co. "Beating the Odds: Uncovering Predictors of Survival in Recurrent Glioblastoma Patients Receiving Bevacizumab" "A Breakthrough in Personalized Medicine: Identifying Key Factors That Influence Patient Outcomes" Price: 27.00€